What are the effects of EIKANCE (0.01% atropine sulfate eye drops)
EIKANCE (0.01% atropine sulfate eye drops)As a treatment drug for myopia, it has been widely used and recognized clinically in recent years.
The core effect of EIKANCE eye drops lies in its ability to effectively control the progression of myopia. By regulating paralysis and dilating the pupil, the drug slows the eyeball's overaccommodation, thereby reducing the rate at which myopia develops. Especially for adolescent pseudomyopia and alleviating the progression of low-to-moderate adolescent myopia, EIKANCE eye drops have shown significant therapeutic effects. According to clinical research data, children who used the drug had significantly lower myopia progression than the control group who did not use the drug, which fully demonstrated its effectiveness in controlling the development of myopia.

Compared with high-concentration atropine, EIKANCE Eye Drops’ 0.01% low-concentration formula has obvious advantages in reducing adverse reactions. Although mild symptoms such as blurred near vision and mydriasis may occur after use, these symptoms are usually transient and the incidence is relatively low. Such drug design allows patients to minimize discomfort and improve treatment compliance while receiving treatment.
EIKANCEeye drops are suitable for myopic patients of multiple ages, especially children aged 4 to 14 years old. This age group is the peak period for the development of myopia, and timely and effective treatment measures are crucial to control the progression of myopia. EIKANCEEye drops have become an important treatment option for patients in this age group due to their safe and effective properties.
The method of use of this eye drop is relatively simple. It is generally recommended to use it before going to bed, one drop at a time, once a day. This frequency of use not only ensures the therapeutic effect of the drug, but also does not bring too much burden to the patient's daily life. At the same time, the single-dose packaging design is also convenient for patients to carry and use.
[ 免责声明 ] 本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。
.jpeg)